In 2023, the import of Streptomycins to Brazil stood at a certain level which is the basis for analyzing trends. The forecasted data indicate a consistent year-on-year increase in imports from 2024 to 2028, from 72.82 to 79.77 thousand kilograms. With these figures, the Compound Annual Growth Rate (CAGR) over this period is expected to reflect steady growth.

Future trends to monitor include:

Potential shifts in demand due to advancements in medical treatment alternatives.
Changes in global supply chain dynamics impacting Brazil's import capacity.
Regulatory developments affecting pharmaceutical imports in Brazil.